CA1025442A - Procede de preparation d'un nouveau sel d'erythromycine - Google Patents
Procede de preparation d'un nouveau sel d'erythromycineInfo
- Publication number
- CA1025442A CA1025442A CA230,434A CA230434A CA1025442A CA 1025442 A CA1025442 A CA 1025442A CA 230434 A CA230434 A CA 230434A CA 1025442 A CA1025442 A CA 1025442A
- Authority
- CA
- Canada
- Prior art keywords
- érythromycine
- pyroglutamate
- eau
- que
- procédé
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
PRECIS DE LA DIVULGATION:
L'invention a pour objet un procédé de préparation du pyroglutamate d'érythromycine qui consiste à faire réagir de l'acide pyroglutamique sur de l'érythromycine base. Le pyroglutamate d'érythromycine obtenu est doué d'une activité
bactériostatique et bactéricide.
L'invention a pour objet un procédé de préparation du pyroglutamate d'érythromycine qui consiste à faire réagir de l'acide pyroglutamique sur de l'érythromycine base. Le pyroglutamate d'érythromycine obtenu est doué d'une activité
bactériostatique et bactéricide.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7423013A FR2302084A1 (fr) | 1974-07-02 | 1974-07-02 | Nouveau sel d'erythromycine, son procede de preparation et son application a titre de medicament |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1025442A true CA1025442A (fr) | 1978-01-31 |
Family
ID=9140790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA230,434A Expired CA1025442A (fr) | 1974-07-02 | 1975-06-30 | Procede de preparation d'un nouveau sel d'erythromycine |
Country Status (11)
Country | Link |
---|---|
JP (1) | JPS5129217A (fr) |
BE (1) | BE830842A (fr) |
CA (1) | CA1025442A (fr) |
CH (1) | CH599152A5 (fr) |
DE (1) | DE2529538A1 (fr) |
DK (1) | DK299375A (fr) |
FR (1) | FR2302084A1 (fr) |
GB (1) | GB1485210A (fr) |
IE (1) | IE41628B1 (fr) |
LU (1) | LU72866A1 (fr) |
NL (1) | NL7507863A (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5633353A (en) * | 1979-08-20 | 1981-04-03 | Toray Ind Inc | Reeling-out method for thread |
DK0804088T3 (da) * | 1994-06-29 | 2000-11-20 | Meiji Seika Kaisha | Stabiliseret sammensætning, der omfatter solisinsulfat |
-
1974
- 1974-07-02 FR FR7423013A patent/FR2302084A1/fr active Granted
-
1975
- 1975-06-30 BE BE157851A patent/BE830842A/fr not_active IP Right Cessation
- 1975-06-30 CA CA230,434A patent/CA1025442A/fr not_active Expired
- 1975-06-30 LU LU72866A patent/LU72866A1/xx unknown
- 1975-07-01 CH CH856875A patent/CH599152A5/xx not_active IP Right Cessation
- 1975-07-01 JP JP8055475A patent/JPS5129217A/ja active Pending
- 1975-07-02 NL NL7507863A patent/NL7507863A/xx not_active Application Discontinuation
- 1975-07-02 DE DE19752529538 patent/DE2529538A1/de not_active Ceased
- 1975-07-02 DK DK299375A patent/DK299375A/da unknown
- 1975-07-02 IE IE147275A patent/IE41628B1/en unknown
- 1975-07-02 GB GB2780975A patent/GB1485210A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
JPS5129217A (en) | 1976-03-12 |
IE41628B1 (en) | 1980-02-13 |
BE830842A (fr) | 1975-12-30 |
DK299375A (da) | 1976-01-03 |
CH599152A5 (fr) | 1978-05-12 |
NL7507863A (nl) | 1976-01-06 |
IE41628L (en) | 1976-01-02 |
FR2302084A1 (fr) | 1976-09-24 |
GB1485210A (en) | 1977-09-08 |
DE2529538A1 (de) | 1976-01-22 |
FR2302084B1 (fr) | 1979-05-18 |
LU72866A1 (fr) | 1976-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2606875C (fr) | Combinaison pharmaceutique comprenant un antibiotique et une substance active choisie parmi le carveol, le thymol, le carvacrol, l'alpha-ionone et beta-ionone | |
FI107994B (fi) | Menetelmä L-DOPA:n etyyliesteriä sisältävän koostumuksen valmistamiseksi | |
FR2658511A1 (fr) | Nouveaux derives de benzimidazole et d'azabenzimidazole, antagonistes des recepteurs au thromboxane; leurs procedes de preparation, compositions pharmaceutiques les contenant. | |
FR2464262A1 (fr) | Sels de la (+)-catechine et compositions les contenant, leur preparation et leur utilisation dans le traitement des maladies degeneratives du tissu conjonctif | |
EP1175217B8 (fr) | Acides carboxyliques de benzoquinolizine antibacteriens optiquement purs, procedes, compositions et procedes de traitement | |
FR2557878A1 (fr) | Compose antibiotique, procede pour le preparer et compositions le contenant | |
CA1025442A (fr) | Procede de preparation d'un nouveau sel d'erythromycine | |
EP0572635B1 (fr) | Composes a structure guanidique et compositions pharmaceutiques les contenant | |
EP0499544B1 (fr) | Utilisation de dérivés de tétrahydrothiénopyridine comme inhibiteurs de l'angiogénèse | |
FR2559484A2 (fr) | Nouveau derive 7-(pyrrol-1-yl) de l'acide 1-ethyl-1,4-dihydro-4-oxo-(1,8-naphtyridin)-3-carboxylique, sa preparation et son application en tant que medicament | |
FR2742660A1 (fr) | Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif | |
FR2574404A1 (fr) | Derives 1-substitues de l'acide 6-fluoro-7-(pyrrol-1-yl)-1,4-dihydro-4-oxoquinoleine-3-carboxylique, leur preparation et leur application en tant que medicaments | |
FR2595697A1 (fr) | Derives de benzyl-pyrimidine, leur procede de preparation ainsi que les compositions en contenant | |
WO1990006931A1 (fr) | Composes organometalliques, leurs modes de preparation et compositions pharmaceutiques les contenant | |
EP0394120A1 (fr) | Dérivés d'isothiazolo-pyrydone azétidinyl substitués, leur préparation et leur application en tant que médicaments | |
CA2400537A1 (fr) | Derives d'aminoacides et leur utilisation en tant qu'inhibiteurs de la nep, l'ace et l'ece | |
CA1045140A (fr) | Ester de n-(8-trifluoromethyl 4-quinolyl) anthranilate | |
LU82614A1 (fr) | Nouveaux derives du tetrahydropyridin-4-yl indole et leurs sels,leur preparation,leur application comme medicaments et les compositions les renfermant | |
EP0092287A2 (fr) | Sels d'acétylcystéine, leur préparation et leur utilisation | |
US20230348365A1 (en) | Compounds for treating infections | |
FR2682378A1 (fr) | Nouveaux derives de l'acide fluoroquinoleine carboxylique-3 et leur preparation. | |
EP0254642A1 (fr) | Dérivés de 1,3-propanediamine, préparation et compositions pharmaceutique les contenant | |
EP0295166A1 (fr) | Compositions pharmaceutiques contenant un mélange de sels de cétoacides et d'amino-acides | |
CA2193096C (fr) | Derives de l'acide guanylique et applications comme medicaments | |
FR1604654A (fr) | Procédé de préparation de dérivés de l'acide céphalosporanique et produits obtenus. |